Opioids Drug - Global Top Players Market Share and Ranking 2026- YH Research

日本语 | 中文

Home > Reports >Pharma & Healthcare > Opioids Drug - Global Top Players Market Share and Ranking 2026

Opioids Drug - Global Top Players Market Share and Ranking 2026

Publication Date: 2026-01-05
Report Id: 2815497
Industry: Pharma & Healthcare
Report Page: 113
Chart: 120

PDF Download

Publication Date: 2026-01-05
Report Id: 2815497
Industry: Pharma & Healthcare
Report Page: 113
Chart: 120

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Opioids Drug Definition
1.2 Global Opioids Drug Market Size and Forecast
1.2.1 By Consumption Value, Global Opioids Drug Market Size, 2021-2032
1.2.2 By Sales Quantity, Global Opioids Drug Market Size, 2021-2032
1.2.3 Global Opioids Drug Average Selling Price (ASP), 2021-2032
1.3 Japan Opioids Drug Market Size and Forecast
1.3.1 By Consumption Value, Japan Opioids Drug Market Size, 2021-2032
1.3.2 By Sales Quantity, Japan Opioids Drug Market Size, 2021-2032
1.3.3 Japan Opioids Drug Average Selling Price (ASP), 2021-2032
1.4 Share of Japan Opioids Drug Market with Respect to the Global Market
1.4.1 By Consumption Value, Japan Opioids Drug Market Share in Global, 2021-2032
1.4.2 By Sales Quantity, Japan Opioids Drug Market Share in Global, 2021-2032
1.4.3 Opioids Drug Market Size: Japan VS Global, 2021-2032
1.5 Opioids Drug Market Dynamics
1.5.1 Opioids Drug Market Drivers
1.5.2 Opioids Drug Market Restraints
1.5.3 Opioids Drug Industry Trends
1.5.4 Opioids Drug Industry Policy

2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Opioids Drug, Global Market Share by Company, 2021-2026
2.2 By Sales Quantity of Opioids Drug, Global Market Share by Company, 2021-2026
2.3 Opioids Drug Average Selling Price (ASP) by Company, 2021-2026
2.4 Global Opioids Drug Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Opioids Drug Concentration Ratio
2.6 Global Opioids Drug Mergers & Acquisitions, Expansion Plans
2.7 Global Opioids Drug Manufacturers Product Type
2.8 Head Office and Opioids Drug Production Site of Key Manufacturer
2.9 Opioids Drug Capacity of Major Manufacturers and Future Plan

3 Japan Leading Manufacturers and Market Share
3.1 By Revenue of Opioids Drug, Japan Market Share by Company, 2021-2026
3.2 By Sales Quantity of Opioids Drug, Japan Market Share by Company, 2021-2026
3.3 Japan Opioids Drug Opioids Drug Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Global Producing Regions
4.1 Global Opioids Drug Capacity, Output and Capacity Utilization, 2021-2032
4.2 Global Opioids Drug Capacity by Region
4.3 Global Opioids Drug Production & Forecast by Region, 2021 VS 2025 VS 2032
4.4 Global Opioids Drug Production by Region, 2021-2032
4.5 Global Opioids Drug Production Market Share & Forecast by Region, 2021-2032

5 Industry Chain Analysis
5.1 Opioids Drug Industry Chain
5.2 Opioids Drug Upstream Analysis
5.2.1 Opioids Drug Core Raw Materials
5.2.2 Main Manufacturers of Opioids Drug Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Opioids Drug Production Mode
5.6 Opioids Drug Procurement Model
5.7 Opioids Drug Industry Sales Model and Sales Channels
5.7.1 Opioids Drug Sales Model
5.7.2 Opioids Drug Typical Distributors

6 Sights by Type
6.1 Opioids Drug Classification by Type
6.1.1 Oxycodone
6.1.2 Hydromorphone
6.1.3 Codeine
6.1.4 Fentanyl
6.2 by Type, Global Opioids Drug Consumption Value & CAGR, 2021 VS 2025 VS 2032
6.3 by Type, Global Opioids Drug Consumption Value, 2021-2032
6.4 by Type, Global Opioids Drug Sales Quantity, 2021-2032
6.5 by Type, Global Opioids Drug Average Selling Price (ASP), 2021-2032

7 Sights by Application
7.1 Opioids Drug Segment by Application
7.1.1 Pain Relief
7.1.2 Anesthesia
7.1.3 Others
7.2 by Application, Global Opioids Drug Consumption Value & CAGR, 2021 VS 2025 VS 2032
7.3 by Application, Global Opioids Drug Consumption Value, 2021-2032
7.4 by Application, Global Opioids Drug Sales Quantity, 2021-2032
7.5 by Application, Global Opioids Drug Price, 2021-2032

8 Sales Sights by Region
8.1 By Region, Global Opioids Drug Consumption Value, 2021 VS 2025 VS 2032
8.2 By Region, Global Opioids Drug Consumption Value, 2021-2032
8.3 By Region, Global Opioids Drug Sales Quantity, 2021-2032
8.4 North America
8.4.1 North America Opioids Drug Market Size & Forecasts, 2021-2032
8.4.2 By Country, North America Opioids Drug Market Size Market Share
8.5 Europe
8.5.1 Europe Opioids Drug Market Size & Forecasts, 2021-2032
8.5.2 By Country, Europe Opioids Drug Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Opioids Drug Market Size & Forecasts, 2021-2032
8.6.2 By Country/Region, Asia Pacific Opioids Drug Market Size Market Share
8.7 South America
8.7.1 South America Opioids Drug Market Size & Forecasts, 2021-2032
8.7.2 By Country, South America Opioids Drug Market Size Market Share
8.8 Middle East & Africa

9 Sales Sights by Country Level
9.1 By Country, Global Opioids Drug Market Size & CAGR, 2021 VS 2025 VS 2032
9.2 By Country, Global Opioids Drug Consumption Value, 2021-2032
9.3 By Country, Global Opioids Drug Sales Quantity, 2021-2032
9.4 United States
9.4.1 United States Opioids Drug Market Size, 2021-2032
9.4.2 by Type, United States Opioids Drug Sales Quantity Market Share, 2025 VS 2032
9.4.3 by Application, United States Opioids Drug Sales Quantity Market Share, 2025 VS 2032
9.5 Europe
9.5.1 Europe Opioids Drug Market Size, 2021-2032
9.5.2 by Type, Europe Opioids Drug Sales Quantity Market Share, 2025 VS 2032
9.5.3 by Application, Europe Opioids Drug Sales Quantity Market Share, 2025 VS 2032
9.6 China
9.6.1 China Opioids Drug Market Size, 2021-2032
9.6.2 by Type, China Opioids Drug Sales Quantity Market Share, 2025 VS 2032
9.6.3 by Application, China Opioids Drug Sales Quantity Market Share, 2025 VS 2032
9.7 Japan
9.7.1 Japan Opioids Drug Market Size, 2021-2032
9.7.2 by Type, Japan Opioids Drug Sales Quantity Market Share, 2025 VS 2032
9.7.3 by Application, Japan Opioids Drug Sales Quantity Market Share, 2025 VS 2032
9.8 South Korea
9.8.1 South Korea Opioids Drug Market Size, 2021-2032
9.8.2 by Type, South Korea Opioids Drug Sales Quantity Market Share, 2025 VS 2032
9.8.3 by Application, South Korea Opioids Drug Sales Quantity Market Share, 2025 VS 2032
9.9 Southeast Asia
9.9.1 Southeast Asia Opioids Drug Market Size, 2021-2032
9.9.2 by Type, Southeast Asia Opioids Drug Sales Quantity Market Share, 2025 VS 2032
9.9.3 by Application, Southeast Asia Opioids Drug Sales Quantity Market Share, 2025 VS 2032
9.10 India
9.10.1 India Opioids Drug Market Size, 2021-2032
9.10.2 by Type, India Opioids Drug Sales Quantity Market Share, 2025 VS 2032
9.10.3 by Application, India Opioids Drug Sales Quantity Market Share, 2025 VS 2032
9.11 Middle East & Africa
9.11.1 Middle East & Africa Opioids Drug Market Size, 2021-2032
9.11.2 by Type, Middle East & Africa Opioids Drug Sales Quantity Market Share, 2025 VS 2032
9.11.3 by Application, Middle East & Africa Opioids Drug Sales Quantity Market Share, 2025 VS 2032

10 Manufacturers Profile
10.1 Teva
10.1.1 Teva Company Information, Head Office, Market Area, and Industry Position
10.1.2 Teva Opioids Drug Models, Specifications, and Application
10.1.3 Teva Opioids Drug Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.1.4 Teva Company Profile and Main Business
10.1.5 Teva Recent Developments
10.2 Purdue Pharma
10.2.1 Purdue Pharma Company Information, Head Office, Market Area, and Industry Position
10.2.2 Purdue Pharma Opioids Drug Models, Specifications, and Application
10.2.3 Purdue Pharma Opioids Drug Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.2.4 Purdue Pharma Company Profile and Main Business
10.2.5 Purdue Pharma Recent Developments
10.3 Mallinckrodt
10.3.1 Mallinckrodt Company Information, Head Office, Market Area, and Industry Position
10.3.2 Mallinckrodt Opioids Drug Models, Specifications, and Application
10.3.3 Mallinckrodt Opioids Drug Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.3.4 Mallinckrodt Company Profile and Main Business
10.3.5 Mallinckrodt Recent Developments
10.4 Amneal Pharma
10.4.1 Amneal Pharma Company Information, Head Office, Market Area, and Industry Position
10.4.2 Amneal Pharma Opioids Drug Models, Specifications, and Application
10.4.3 Amneal Pharma Opioids Drug Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.4.4 Amneal Pharma Company Profile and Main Business
10.4.5 Amneal Pharma Recent Developments
10.5 Collegium
10.5.1 Collegium Company Information, Head Office, Market Area, and Industry Position
10.5.2 Collegium Opioids Drug Models, Specifications, and Application
10.5.3 Collegium Opioids Drug Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.5.4 Collegium Company Profile and Main Business
10.5.5 Collegium Recent Developments
10.6 J&J
10.6.1 J&J Company Information, Head Office, Market Area, and Industry Position
10.6.2 J&J Opioids Drug Models, Specifications, and Application
10.6.3 J&J Opioids Drug Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.6.4 J&J Company Profile and Main Business
10.6.5 J&J Recent Developments
10.7 Endo
10.7.1 Endo Company Information, Head Office, Market Area, and Industry Position
10.7.2 Endo Opioids Drug Models, Specifications, and Application
10.7.3 Endo Opioids Drug Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.7.4 Endo Company Profile and Main Business
10.7.5 Endo Recent Developments
10.8 Pfizer
10.8.1 Pfizer Company Information, Head Office, Market Area, and Industry Position
10.8.2 Pfizer Opioids Drug Models, Specifications, and Application
10.8.3 Pfizer Opioids Drug Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.8.4 Pfizer Company Profile and Main Business
10.8.5 Pfizer Recent Developments
10.9 INSYS
10.9.1 INSYS Company Information, Head Office, Market Area, and Industry Position
10.9.2 INSYS Opioids Drug Models, Specifications, and Application
10.9.3 INSYS Opioids Drug Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.9.4 INSYS Company Profile and Main Business
10.9.5 INSYS Recent Developments
10.10 Mylan
10.10.1 Mylan Company Information, Head Office, Market Area, and Industry Position
10.10.2 Mylan Opioids Drug Models, Specifications, and Application
10.10.3 Mylan Opioids Drug Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.10.4 Mylan Company Profile and Main Business
10.10.5 Mylan Recent Developments
10.11 Hikma
10.11.1 Hikma Company Information, Head Office, Market Area, and Industry Position
10.11.2 Hikma Opioids Drug Models, Specifications, and Application
10.11.3 Hikma Opioids Drug Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.11.4 Hikma Company Profile and Main Business
10.11.5 Hikma Recent Developments
10.12 Egalet
10.12.1 Egalet Company Information, Head Office, Market Area, and Industry Position
10.12.2 Egalet Opioids Drug Models, Specifications, and Application
10.12.3 Egalet Opioids Drug Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.12.4 Egalet Company Profile and Main Business
10.12.5 Egalet Recent Developments

11 Conclusion

12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer

According to YH Research, the global market for Opioids Drug should grow from US$ 10140 million in 2025 to US$ 9007 million by 2032, with a CAGR of -1.7% for the period of 2026-2032.

The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.

Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.

Global Opioids Drug main players are Purdue Pharma, Teva, Pfizer, Hikma, etc. Global top four manufacturers hold a share over 40%. North America is the largest market, with a share nearly 70%.

This report studies and analyses global Opioids Drug status and future trends, helps the client to determine the Opioids Drug market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Opioids Drug, and provides market size (in M Units & US$ million) and Year-over-Year growth, considering 2025 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Opioids Drug market size, history data 2021-2025, and forecast data 2026-2032, (US$ million) & (M Units)
(2) Global Opioids Drug sales, revenue, price by company, market share and industry ranking 2021-2026, (US$ million) & (M Units)
(3) Japan Opioids Drug sales, revenue, price by company, market share and industry ranking 2021-2026, (US$ million) & (M Units)
(4) Global Opioids Drug key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Opioids Drug key producing regions, capacity, production, and year over year growth
(6) Opioids Drug industry chains, upstream, midstream and downstream
Market segment by players, this report covers
    Teva
    Purdue Pharma
    Mallinckrodt
    Amneal Pharma
    Collegium
    J&J
    Endo
    Pfizer
    INSYS
    Mylan
    Hikma
    Egalet

Market segment by Type, covers
    Oxycodone
    Hydromorphone
    Codeine
    Fentanyl

Market segment by Application, can be divided into
    Pain Relief
    Anesthesia
    Others

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Opioids Drug product scope, global sales quantity, value and average price, Japan sales quantity, value and average price, development opportunities, challenges, trends, and policies
Chapter 2: Global Opioids Drug market share and ranking of major manufacturers, sales quantity, revenue, average price, 2021-2026
Chapter 3: Japan Opioids Drug market share and ranking of major manufacturers, sales quantity, revenue, average price, 2021-2026
Chapter 4: Global key producing regions of Opioids Drug, percent & CAGR, 2021-2032
Chapter 5: Opioids Drug industry chain, upstream, medium-stream, and downstream
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2021-2032
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2021-2032
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2021-2032
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2021-2032
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin
Chapter 11: Conclusions